Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions
Coronary Artery Disease
Interventions
DRUG

Ticagrelor 60mg

Patients in the ticagrelor arm will receive a 180 mg loading dose of ticagrelor followed by ticagrelor 60 mg bid maintenance dose for 30±5 days. Patients will maintain aspirin 81 mg once daily for the duration of the study.

DRUG

Clopidogrel

Patients in the clopidogrel arm will continue to receive clopidogrel 75 mg/daily for 30±5 days. Patients will maintain aspirin 81 mg once daily for the duration of the study.

Trial Locations (1)

32209

RECRUITING

University of Florida Jacksonville, Jacksonville

All Listed Sponsors
collaborator

Scott R. MacKenzie Foundation

OTHER

lead

University of Florida

OTHER

NCT06228456 - Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter